Stiliden

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Stiliden

Quick Facts

Property Description
Active Ingredient Paroxetine
Form Oral Solid Forms (Film-Coated Tablets)
Pharmacological Class Selective Serotonin Reuptake Inhibitor (SSRI)
General Purpose Systemic management of mood and emotional stability
Origin Synthetic Compound

What Type of Medicine is Stiliden?

Stiliden is a specific prescription-only medicine whose identity is established by its single active compound, Paroxetine. It is classified as an Antidepressant and specifically belongs to the pharmacological group known as Selective Serotonin Reuptake Inhibitors (SSRIs). This drug works by acting on the central nervous system to help regulate mood.

This medication is fundamentally a synthetic compound, manufactured to ensure purity and chemical consistency. As a psychotropic drug, Stiliden's mechanism centers on influencing chemical activity within the brain. Paroxetine is categorized within the class of psychoanaleptics, which signifies its recognized role in supporting mental function and emotional well-being.


Composition and Form of Stiliden

The composition of Stiliden centers exclusively on a single active substance, Paroxetine, typically provided in the form of the salt Paroxetine hydrochloride or mesylate. This makes it a single active ingredient product. The known pharmacological properties of the active substance support its clinical use.

Stiliden is prepared for oral administration and is found in oral solid forms, such as film-coated tablets or controlled-release tablets. The use of a film-coating is a distinguishing formulation feature designed to potentially improve patient tolerance and ease of swallowing. The use of a single active ingredient product ensures that the therapeutic action is solely attributable to the defined effects of Paroxetine.


General Purpose of Stiliden (High-Level)

Stiliden's primary function is to achieve neurotransmitter modulation in the brain, supporting emotional equilibrium. It works through serotonin reuptake inhibition, which is the core principle of its high-level mechanism of action.

This process prevents nerve cells from rapidly absorbing the chemical messenger serotonin after its release, thereby increasing its availability in the synaptic space. The overall benefit is linked to restoring a more balanced level of serotonin activity, and its typical use is aimed at stabilizing mood and reducing excessive emotional tension expected from this type of SSRI antidepressant.

Regulatory References

  1. Paroxetine: MedlinePlus Drug Information

What side effects are possible with Stiliden?

Possible Side Effects and Safety Information

Stiliden's official safety profile, as documented by government regulatory authorities, classifies adverse reactions by their expected frequency and the physiological system affected.

Adverse Reaction Scope

Safety Entity Regulatory Classification Summary
Very Common Reactions Nausea, Impaired concentration, and sexual dysfunction (e.g., decreased libido) are listed among the most frequently observed effects (1/10).
Common Reactions Reactions occurring in 1% to 10% of users include headache, somnolence, insomnia, dizziness, tremor, sweating, dry mouth, diarrhea, and constipation, falling within the Nervous System and Gastrointestinal System-Organ Classes.
System-Organ Classes Adverse effects are documented across major systems, including Gastrointestinal, Nervous System, Psychiatric, Ophthalmic, Metabolic/Nutritional (e.g., Hyponatremia), and Reproductive Systems.
Serious Adverse Reactions Officially documented serious concerns include the risk of Suicidal Thoughts and Behaviors, particularly in young adults (le 24), Serotonin Syndrome, clinically significant Abnormal Bleeding Events, Activation of Mania/Hypomania, and Angle-Closure Glaucoma.

Population-Specific Safety Considerations

Official labeling mandates safety constraints for specific groups: use in children and adolescents (under 18) is generally not recommended due to observed risks of suicidal behavior. Dosage reduction is required for older adults and individuals with severe renal or hepatic impairment due to altered plasma concentrations. For pregnancy, first-trimester exposure carries an increased risk of cardiovascular malformations in the fetus.

Time- and Restriction-Related Patterns

The risk of Suicidal Thoughts and Behaviors is noted to be heightened during the initial few months of therapy or at times of dose change. The medication is contraindicated for use with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of Serotonin Syndrome and is also restricted from concomitant use with Pimozide.

Overdose and Emergency Response

Overdose and When to Seek Help

The most significant and life-threatening risk associated with an overdose of Stiliden is severe, potentially fatal liver damage (hepatotoxicity). This damage can rapidly progress to liver failure and, in severe instances, necessitate liver transplantation or lead to death. The risk of severe injury is heightened in cases involving a single acute overdose or repeated administration of doses exceeding the recommended maximum.

Clinical Manifestations and Urgency

Symptoms of an overdose can be non-specific or absent in the initial hours following ingestion. While some patients may experience early signs like nausea, vomiting, or abdominal pain, these symptoms are not a reliable indicator of the severity of the developing toxicity. Crucially, the most serious consequences of liver injury, such as jaundice (yellowing of the skin and eyes) and confusion, may be significantly delayed, sometimes becoming apparent only 24 to 48 hours or more after the toxic dose was taken.

Required Emergency Action

Due to the latency of severe injury, regulatory guidance emphasizes that immediate emergency medical help must be sought following any suspected overdose, even if no symptoms are present. The decision to initiate life-saving treatments, such as administering a specific antidote, must be made promptly and should not wait for symptoms to develop or for full laboratory confirmation of drug levels. Delayed treatment substantially increases the risk of severe morbidity or mortality.

Therapeutic Uses of Stiliden

What Stiliden Treats: Main Uses and Benefits

Stiliden (Paroxetine) is commonly used to help manage symptoms across multiple domains where heightened emotional and physiological tension is present. Its applications generally include conditions characterized by periods of intensified or fluctuating manifestations, particularly when supportive symptomatic assistance is needed to help cope more steadily with symptom fluctuations.

This medication is applied in addressing core conditions such as Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Panic Disorder, Posttraumatic Stress Disorder (PTSD), and Obsessive-Compulsive Disorder (OCD). It is also considered relevant for managing symptoms associated with Premenstrual Dysphoric Disorder (PMDD) and certain moderate-to-severe Vasomotor Symptoms of menopause.

The drug supports general well-being during symptomatic phases and may help with easing the overall symptom load over time, providing supportive relief when symptoms interfere with routine activities.


Quick Fact Targeted Symptom Domain
Primary Focus Chronic Worry and Pervasive Low Mood
Acute Support Panic Attacks and Trauma-Related Hyperarousal
Cyclic Symptom Management Severe Premenstrual Mood Swings (PMDD)
VMS Management Moderate-to-Severe Hot Flashes (VMS)

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Stiliden?

The population eligibility for Stiliden (Paroxetine) is strictly defined by regulatory authorities based on age, co-administered medications, and physiological status.

Stiliden is contraindicated and must not be used by patients with a known hypersensitivity to paroxetine or any ingredient in the formulation. Use is also strictly prohibited with certain medications, including Monoamine Oxidase Inhibitors (MAOIs), Thioridazine, and Pimozide.

Eligibility and Restrictions

The medicine is officially approved for use in adults aged 18 years and older. Use is not approved or recommended for children and adolescents (under 18 years).

Conditional use applies to populations who require special regulatory caution, including:

  • Patients with severe renal impairment or hepatic impairment (requires a restricted initial administration).
  • Older adults (requires a reduced initial dose).
  • Pregnancy (restricted use due to documented risk of cardiovascular malformations in the first trimester, and risk of Persistent Pulmonary Hypertension of the Newborn in late pregnancy).

The official label mandates screening for bipolar disorder prior to initiation and advises caution for patients with a history of seizure disorders.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Stiliden (Paroxetine) has officially documented interactions with other medicines and products, which are detailed in regulatory prescribing information.

Interaction Classification Interacting Agents Rationale in Regulatory Documents
Contraindicated MAOIs (including Linezolid and IV Methylene Blue) Significant risk of Serotonin Syndrome [1.6, 3.4, 3.7].
Thioridazine and Pimozide Elevated plasma levels increase risk of QTc prolongation [1.6, 3.4].
Clinically Significant CYP2D6 Substrates (e.g., Desipramine, Risperidone) Stiliden is a potent CYP2D6 inhibitor, increasing substrate drug exposure [1.1, 3.4].
Tamoxifen Inhibition of CYP2D6 reduces the formation of Tamoxifen's active metabolite [1.7, 3.6].
Serotonergic Agents (e.g., Triptans, Lithium, St. John's Wort) Risk of additive serotonergic effects [3.7].
Bleeding Risk Agents (e.g., NSAIDs, Warfarin) Risk of additive effect on hemostasis [1.7, 3.7].

Procedural and Pharmacokinetic Constraints

The regulatory label mandates strict time-separation rules when switching to or from Monoamine Oxidase Inhibitors (MAOIs). At least 14 days must elapse after discontinuing an MAOI before Stiliden can be started, and vice versa [1.7, 2.6].

Co-administration with highly protein-bound drugs, such as Warfarin, requires monitoring due to potential for interaction [3.6]. Additionally, the official documents note that Stiliden plasma concentrations are increased in patients with severe renal impairment or hepatic impairment, which affects the interaction profile in these populations [1.1, 2.5].

Mechanism of Action

Stiliden: Mechanism of Action

Stiliden exerts its action primarily by modulating excitatory neurotransmission within the central nervous system (CNS). The compound acts as a non-competitive antagonist at N-methyl-D-aspartate (NMDA) receptors, particularly those containing the GluN2B subunit. This interaction restricts the opening of the receptor-associated ion channel, limiting the influx of calcium ions ( Ca^2+).

This primary action is reinforced by the drug's role as a blocker of specific Voltage-Gated Calcium Channels (VGCCs) and its ability to inhibit Neuronal Nitric Oxide Synthase (nNOS). By limiting the influx of Ca^2+ and suppressing nNOS activity, Stiliden interrupts the molecular cascade that leads to the excessive generation of nitric oxide (NO) and subsequent reactive nitrogen species.

Collectively, this multi-target activity reduces pathological neuronal overactivity and decreases markers of oxidative stress, limiting the processes associated with cellular destruction (excitotoxicity). The resulting physiological consequence is a sustained, modulated signaling state within the CNS.

Dosage and Administration Information

Official Administration Guidelines

Stiliden (Paroxetine) is administered exclusively through the oral route, available as both immediate-release (IR) tablets and specialized controlled-release (CR) tablets. The established pattern of use is a single daily dose, which is typically directed for morning intake.

Established dosing regimens follow a systematic approach, starting at a low dose, such as 10 mg or 20 mg daily for IR tablets, depending on the condition. Any necessary increase toward the usual maintenance range (20 mg to 60 mg daily) must be implemented gradually, with adjustments occurring at intervals of no less than one week. This structured titration schedule is a core component of the usage protocol.

For administration specifics, IR tablets can generally be taken with or without food. However, the controlled-release tablets must be swallowed whole to preserve their intended release characteristics and cannot be crushed or chewed.

Dosage guidelines include distinct modifications for specific patient populations. Older adults and individuals with documented severe renal or hepatic impairment are typically started on a lower initial dose, and their total maximum daily dose is also restricted below the standard adult maximum. When usage is concluded, the dosage must always be gradually reduced (tapered) over a period of time, as abrupt cessation is avoided in accordance with standard clinical protocols.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section provides background on the compound and summarizes the most relevant clinical studies. The compound has been studied to assess its effect on symptom severity and its focus on key inflammatory pathways. This information is for review only and should not replace consultation with a healthcare specialist regarding treatment decisions.


Overview of Key Clinical Trials

Primary Efficacy Research

A large Phase III Randomized Controlled Trial (RCT) was conducted, where researchers evaluated whether the compound was associated with changes in joint mobility measures and short-term changes in measures of chronic inflammation.

  • Study Design: A randomized, double-blind, placebo-controlled trial involving 520 adult patients with the condition.
  • Key Findings on Pain: The researchers reported findings suggesting an observed change in pain scores over a 12-month follow-up period.
  • Secondary Endpoint: Researchers explored changes in biomarkers related to disease progression.

Study Data on Safety and Tolerability

Safety data from the studies focused on adult patients with mild-to-moderate disease.

  • Common Adverse Events (AEs): The studies reported findings related to AEs, including gastrointestinal upset and headache.
  • Serious Adverse Events (SAEs): Serious AEs were reported at a rate comparable to the placebo group, emphasizing the need for ongoing monitoring.

Combination Therapy Studies

Research examined whether this compound in combination with an existing standard-of-care medication was associated with long-term follow-up measures. The research explored whether adding the compound to the existing regimen was associated with different outcomes in disease activity scores.

  • Overall Conclusion: Overall, the body of evidence was reviewed to assess the study profile and reported findings across the different treatment groups.

Frequently Asked Questions (FAQ)

Common questions about Stiliden (FAQ)


Q: How quickly does Stiliden start working?

Studies and official information indicate that while some minor changes may be observed earlier, the full intended therapeutic effect of Stiliden typically requires four to six weeks of consistent use to develop fully. This timeframe is consistent with the process of modulating the targeted brain chemistry to achieve clinical benefit.

Q: What happens if I miss a dose of Stiliden?

Regulatory guidance typically states that if a missed dose is remembered, it may be taken unless it is almost time for the next scheduled dose. If it is nearly time for the next dose, the regulatory recommendation is to skip the missed dose entirely. Official documents strictly advise against taking two doses at the same time to make up for a missed one.

Q: Can I drink coffee while taking Stiliden?

Regulatory documents do not contain a specific contraindication for the consumption of coffee or caffeine while using Stiliden. However, research has explored that caffeine may potentially increase the concentration of the drug in the body. If any changes in side effects are experienced, it is consistent with official guidance to inform a healthcare provider.

Q: Does Stiliden affect birth control pills?

Official drug labeling indicates that Stiliden is extensively metabolized by the body into substances with minimal inhibitory potency. Studies suggest that Stiliden is not expected to significantly interfere with the liver enzymes (specifically CYP3A4) responsible for metabolizing most oral contraceptives.

Q: Is Stiliden safe for older adults?

Stiliden is approved for use in adults, but its use in older adults is subject to special regulatory caution. Official documents mandate starting with a lower initial dose than for younger adults. The maximum daily dose for older adults is also restricted due to potential changes in how the body processes the medication.

Q: How is Stiliden different from other drugs for the same condition?

Stiliden’s primary classification by regulatory agencies is as a Selective Serotonin Reuptake Inhibitor (SSRI). This means its primary action is focused on increasing the availability of the neurotransmitter serotonin in the brain. This pharmacological approach defines its difference from other drug classes that utilize alternative chemical pathways.

Q: Will taking Stiliden impact my ability to drive or operate machinery?

Official warnings note that Stiliden can cause side effects such as dizziness, drowsiness, or impaired concentration. For this reason, regulatory warnings advise against driving or operating hazardous machinery until an individual is reasonably certain how the medication affects them.

Q: Are there any specific foods to avoid when taking Stiliden?

According to the official product information, there are no specific foods listed as being prohibited while using Stiliden. The labeling describes that Immediate-Release tablets are generally permitted to be taken with or without food.

Q: Can I take Stiliden if I have high blood pressure?

Stiliden, as an SSRI, generally has a limited expected effect on the cardiovascular system compared to some other drug classes. However, rare, severe adverse reactions such as Serotonin Syndrome can potentially include high blood pressure as a symptom. Any pre-existing heart or blood pressure conditions should be carefully reviewed by a healthcare provider.

Q: Are there restrictions on mixing Stiliden with alcohol?

Official drug information advises that using Stiliden with alcohol may increase nervous system side effects, such as dizziness, drowsiness, confusion, and difficulty concentrating. For this reason, official drug information advises avoiding or limiting the use of alcohol while taking this medicine.

Q: How long do I need to take Stiliden for its intended effect?

Regulatory guidelines state that the duration of treatment is determined by the healthcare provider based on the condition being addressed. Patients are advised that treatment must be continued as prescribed and is subject to regular review, as the full therapeutic benefit may take several weeks to fully appear.

Q: What is the experience of most people after stopping Stiliden?

Official guidelines emphasize that the dosage must always be gradually reduced (tapered) over a period of time. Abrupt cessation is strongly advised against, as it can potentially lead to antidepressant discontinuation syndrome. This experience may include symptoms such as dizziness, feeling sick, and electric shock-like sensations.

Q: What should I do if I suspect an overdose of Stiliden?

In the event of a suspected overdose, the primary official instruction is to seek immediate medical attention or call an emergency line right away. Symptoms could potentially include vomiting, shaking, a fast heart rate, or high temperature, which require urgent evaluation by a medical professional.

Q: How does Stiliden affect blood sugar levels?

Official documentation mentions adverse effects related to the metabolic/nutritional systems, such as Hyponatremia (low sodium levels). While no direct statement about typical blood sugar is made, some reports have suggested that SSRIs may increase insulin sensitivity in certain patients, which has been associated with reports of low blood sugar.

Q: What happens if I take Stiliden past its expiration date?

Official patient information explicitly states that the medicine should not be used if the expiration date (EXP) printed on the pack has passed. This instruction is to help ensure the medicine maintains its intended quality and stability.

Q: What is known about Stiliden use while breastfeeding?

Data from authoritative reviewers indicates that the active ingredient in Stiliden is often considered one of the preferred antidepressants during breastfeeding due to the low levels found in breastmilk. However, official guidance recommends that infants are monitored for potential effects such as agitation or changes in feeding habits.

Q: What is the typical time frame before the drug's full effect is seen?

According to general prescribing information, the time frame for Stiliden to reach its full intended therapeutic effect is generally described as four to six weeks after beginning treatment.

Q: Can Stiliden cause drowsiness?

Somnolence (sleepiness or drowsiness) is listed as a Common Reaction in the official safety profile, meaning it may affect between 1% and 10% of users. This side effect is referenced in the regulatory warnings about driving or operating machinery.

Q: Are headaches a common side effect of Stiliden?

Headache is listed as a Common Reaction in the official safety profile. This means that, based on clinical trials, it is expected to affect between 1% and 10% of users.

Q: What are the most serious side effects I should know about Stiliden?

Officially documented serious concerns listed in the regulatory profile include the risk of Suicidal Thoughts and Behaviors (especially in young adults), Serotonin Syndrome, clinically significant Abnormal Bleeding Events, and the potential for Activation of Mania/Hypomania and Angle-Closure Glaucoma.

Q: Does Stiliden interact with common over-the-counter pain relievers?

Stiliden interacts with medications that affect blood clotting, such as Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which include many common over-the-counter pain relievers. The combination carries a documented risk of an additive effect on blood coagulation and a potential increased risk of bleeding.

Q: Can Stiliden interact with natural supplements or vitamins?

The medication has a documented interaction with the herbal supplement St. John's Wort. The official label lists this combination as having a risk of additive serotonergic effects, which may potentially increase the chance of developing Serotonin Syndrome.

Q: Is it normal to feel a slight upset stomach when starting Stiliden?

Nausea (feeling sick or upset stomach) is listed as a Very Common Reaction in the official safety profile, meaning it may affect 10% or more of users. Other gastrointestinal issues, like diarrhea or constipation, are also listed as common, particularly upon starting treatment.

Q: Does Stiliden cause weight changes?

Official safety data lists loss of appetite or decreased appetite as Common Reactions. However, some prescribing information indicates that weight gain has also been observed and reported in some studies, particularly during long-term use.

How should Stiliden be stored and disposed of?

Official Storage and Disposal Instructions for Stiliden (Paroxetine Tablets)

The storage and disposal requirements for Stiliden tablets are defined by regulatory labeling to maintain product quality and safety.

Storage Domain Required Condition
Temperature Store at Controlled Room Temperature 20°–25°C (68°–77°F).
Protection Keep in the original, tightly closed container to protect from moisture and light.
Child Safety Must be kept out of the sight and reach of children.

Regulatory documents specify that Stiliden should not be disposed of using household waste or flushed down the toilet, as this may release the product into the environment. Disposal of unused or expired medicine must be carried out according to local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Stiliden found in:

A-Z Index: